Michael Leadbetter

3 Patents

• US120168562024

  Compounds and Methods for Inhibiting Nhe-mediated Antiport in the Treatment of Disorders Associated with Fluid Retention or Salt Overload and Gastrointestinal Tract Disorders

  Ardelyx, Inc.

  0 cites
• US118589592024

  Glycyrrhetinic Acid Derivatives for Use in Treating Hyperkalemia

  Ardelyx, Inc.

  0 cites
• US117683192023

  Glycyrrhetinic Acid Derivatives for Treating Hyperkalemia

  Ardelyx, Inc.

  0 cites